Superdisintegrants Market Size, Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2021 – 2027
Report ID: GMI3938
Superdisintegrants Market size is projected to experience significant growth from 2019 to 2025.
Pharmaceutical consumption continues to increase in order to meet the growing needs for patients suffering from various age-related and chronic diseases. According to the study conducted by the Organization for Economic Co-operation and Development (OECD), the pharmaceutical consumption is very high globally. Moreover, the solid dosage medicines still hold significant revenue in the overall pharmaceutical industry, thus increasing the demand for superdisintegrants in the future.
Growing adoption of orally disintegrating tablets (ODTs) and increasing emergence of new superdisintegrants for the pharmaceutical industry will stimulate the global superdisintegrants business growth in the coming years. Extensive usage of superdisintegrants in the formulation of orally disintegrating tablets for antipsychotics, antidepressants, antimigraine, and sedatives will drive the growth of this market. Additionally, various desirable features such as high compatibility, improved bioavailability, and efficient compressibility will escalate the demand of superdisintegrants market over the projected timeframe.
Natural superdisintegrants segment will hold a significant revenue size over the forecast years due to its rapid disintegration and dissolution enhancing effect. Natural polymers increase the solubility of the poorly water-soluble drug. The advantages of natural superdisintegrants over the synthetic include non-toxicity, chemically inert nature, less expensive, and widely available. Moreover, extensive research has been carried out for the development of novel natural disintegrating agents due to its biodegradable feature, thereby augmenting the demand for natural superdisintegrants in the coming years.
Tablets segment will show momentous growth over the projected timeframe due to the extensive usage of fast-disintegrating tablets and orally disintegrating tablets (ODT) among healthcare providers and patients globally. These tablets possess various advantages such as better pre-gastric absorption, enhanced drug bioavailability, ease of administration, accurate dosing, and longer shelf life. Additionally, availability of various oral disintegrating tablets along with the addition of quick dissolving dosage form will accelerate segmental growth during the forecast period.
Growing burden of neurological disorders will stimulate the global superdisintegrants market growth in the projected timeframe. According to the World Health Organization (WHO), in 2018, more than 300 million individuals are suffering from depression globally. Also, depression is the leading cause of disability and mostly seen in women than in men. Moreover, such disorders will upsurge the demand for effective therapies thereby, increasing the usage of over-the-counter (OTC) drugs in the treatment of neurological disorders. Aforementioned factors will enhance segmental growth during the forecast period.
Germany superdisintegrants market size is estimated to witness lucrative growth over the forecast period due to the presence of major pharmaceutical industry players in the country. Better innovation and utilization of advanced techniques in the manufacture of superdisintegrants will surge the demand for market growth. Moreover, rising emphasis on superior pharmaceutical products coupled with growing demand for generic drugs will augment Germany superdisintegrants industry growth.
India superdisintegrants market is estimated to witness lucrative growth over the forecast period due to the increase in manufacturing of new superdisintegrants and growing adoption of novel drug delivery technologies. Growing outsourcing of excipient manufacturing to developing countries like India and China coupled with increasing financial support from the government for the development of innovative oral dosage forms will accelerate market growth in India.
Few of the major players operating in the global superdisintegrants market share include Ashland, BASF SE, JRS Pharma, DFE Pharma and Roquette Freres among other players. These industry players are involved in various strategic appliances such as mergers & acquisitions, partnerships, collaborations, and new product launch to enhance profitability and company growth.
Superdisintegrants Market by Product, 2014-2025 (USD Million)
- Natural Superdisintegrants
- Plantago ovata mucilage
- Synthetic Superdisintegrants
- Croscarmellose Sodium/AC-Di-Sol
- Sodium Starch Glycolate
- Low-Substituted Hydroxypropyl Cellulose (L-HPC)
- Calcium Silicates
- Ion Exchange Resins
Superdisintegrants Market by Dosage form, 2014-2025 (USD Million)
- Mouth-dissolving Films
Superdisintegrants Market by Therapeutic area, 2014-2025 (USD Million)
- Gastrointestinal Diseases
- Neurological Diseases
- Infectious Diseases
- Cardiovascular Diseases
- Hematological Diseases
- Inflammatory Diseases
The above information is provided for the following regions and countries:
- North America
- Asia Pacific
- Latin America
- Middle East and Africa
- South Africa
- Saudi Arabia
- BASF SE
- JRS Pharma
- DFE Pharma
- Roquette Freres
- Asahi Kasei Corporation
- Corel Pharma Chem
- Avantor, Inc.
- Merck KGaA
- DuPont de Nemours, Inc.
What Information does this report contain?
Customize this Report
Our Market Research Reports Include:
- Market snapshot
- Market Segmentation
- Value Chain Analysis
- Growth Dynamics
- Potential Market Opportunities
- Regulatory Overview
- Technology Evolution
- Innovation & Sustainability